G Protein Coupled Receptors Gpcrs Market
G-Protein Coupled Receptors (GPCRs) Market Forecasts to 2030 - Global Analysis By Product (Cell Culture Reagents, Cell Lines, Detection Kits and Ligands), By Assay Type (cAMP Functional Assays, Calcium Functional Assays, Internalization Assays and Other Assay Types), Application and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $3.70 BN |
|
Projected Year Value (2030) |
US $5.98 BN |
|
CAGR (2023-2030) |
7.1% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global G-Protein Coupled Receptors (GPCRs) Market is accounted for $3.70 billion in 2023 and is expected to reach $5.98 billion by 2030 growing at a CAGR of 7.1% during the forecast period. The diverse group of membrane receptors known as G-Protein Coupled Receptors (GPCRs), also referred to as seven-(pass)-trans membrane receptors. These can be found in the cell membrane and are in charge of interacting with external chemicals and relaying signals to intracellular molecules. GPCRs are cell surface receptors that function as an inbox for messages delivered as peptides, proteins, light energy, lipids, and sugars. These receptors are frequently employed in the management of a wide range of illnesses, including inflammatory disorders, metabolic disturbances, cardiac disorders, cancer, and monogenic disorders.
According to the American Heart Association's 2021 Journal, more than 130 million adults in the United States are expected to have some type of heart disease by 2035.
-Market-fig-2.png)
Market Dynamics:
Driver:
Increasing prevalence of chronic diseases
The increasing prevalence of chronic diseases serves as a robust driver in the G-Protein Coupled Receptors (GPCRs) market. GPCRs play a pivotal role in regulating numerous physiological processes, making them valuable drug targets. With a growing global burden of chronic conditions such as diabetes, cardiovascular diseases, and neurodegenerative disorders, the demand for pharmaceutical interventions that target GPCRs is on the rise. Researchers are exploring GPCRs for innovative therapeutic solutions, which has stimulated research and development in the pharmaceutical industry.
Restraint:
High cost of G-protein coupled receptors (GPCRs) cell lines
The high price of G-Protein Coupled Receptors (GPCRs) cell lines represents a significant restraint in the GPCR market. The substantial cost associated with acquiring these cell lines can be prohibitive for smaller research institutions and biotech startups, limiting their ability to engage in GPCR-related research and drug development. This pricing barrier can stifle innovation, reduce competition, and impede scientific progress in understanding and targeting GPCRs, potentially slowing down the discovery of new pharmaceuticals.
Opportunity:
Adoption of GPCRs in drug discovery across the world
The widespread adoption of G-Protein Coupled Receptors (GPCRs) in drug discovery represents a significant opportunity for the market. GPCRs are a diverse class of drug targets involved in regulating various physiological processes, making them crucial for pharmaceutical research. Their versatility and involvement in numerous diseases, including cancer, neurological disorders, and metabolic conditions, have led to increased interest. As drug discovery efforts become increasingly globalized, GPCRs offer a promising avenue for innovative drug development. This adoption of GPCRs as targets for new therapeutics enhances research and development initiatives, paving the way for novel medications, and underscores the substantial growth potential in the GPCR market on a global scale.
Threat:
Complexity of the GPCR signalling system
The family of cell surface receptors known as GPCRs includes many different types of receptors and has complex signaling systems. It can be difficult to comprehend how they interact with different ligands and downstream signaling cascades, which makes it more difficult to find new drugs and develop existing ones. Because of this complexity, it is harder to predict a drug candidate's effectiveness, and there is a higher risk of unanticipated negative effects. Additionally, a lot of research, cutting-edge technology, and collaboration are needed, which are expensive and time-consuming. All of these elements are expected to restrain market growth.
Covid-19 Impact:
The G-Protein Coupled Receptors (GPCR) market has been significantly impacted by the COVID-19 pandemic in a number of ways. Lab closures and resource redistribution towards pandemic-related studies resulted in a slowdown in the study of GPCRs, which are essential for drug discovery. On the other hand, it has hastened the adoption of computational and virtual screening techniques for GPCR drug development. Due to the role that GPCRs play in immune responses and the potential they provide for treating viral infections, the market saw an increase in demand for GPCR-targeted therapies. Overall, the pandemic affected the GPCR market by fostering innovation and stifling it with a move toward digital methods.
The cAMP functional assays segment is expected to be the largest during the forecast period
The cAMP functional assays segment is anticipated to register the largest market share in the anticipated timeframe. This is due to its critical role in drug discovery and understanding cellular signaling. cAMP assays are widely utilized for studying GPCR activation and signaling pathways, making them integral to identifying potential drug candidates. They enable researchers to assess GPCR responses to ligands, providing valuable insights into drug efficacy and safety. With the rising demand for GPCR-targeted drugs, cAMP assays have gained prominence, driving their dominance in the market.
The cancer research segment is expected to have the highest CAGR during the forecast period
The cancer research segment is experiencing the highest growth rate during the forecast period due to the pivotal role GPCRs play in cancer progression. Research has revealed GPCRs' involvement in tumor growth, angiogenesis, and metastasis, making them attractive targets for cancer therapy. Additionally, the market's growth is fueled by the increased emphasis on personalized medicine and the development of GPCR-targeted cancer drugs. Advances in understanding GPCR signaling in cancer have led to a surge in innovative therapies and a growing demand for GPCR-related research tools, positioning this segment for substantial expansion in the near future.
Region with largest share:
During the forecast period, North America is anticipated to witness largest market share, led by the economically and technologically developed nations of the United States, Canada, and Mexico. According to the American Cancer Society, there will be 1.9 million new cases of cancer and 609,360 cancer-related deaths in the United States alone in 2022. In a similar vein, the Canadian Cancer Statistics 2021 revealed that roughly 2 in 5 Canadians will receive a cancer diagnosis during their lifetime and that 1 in 4 will pass away from the disease. Further bolstering market growth in North America is the burden of chronic diseases, particularly in cardiovascular and cancer applications, which is raising demand for cutting-edge therapies and treatments.
Region with highest CAGR:
Asia-Pacific is expected to experience the highest growth during the forecast period due to the presence of a number of young businesses like NB Health Laboratory, HD Biosciences Co., Ltd., and Sosei Heptares. Regional growth is influenced by the number of initiatives companies take to enhance their market presence. Furthermore, regional expansion is also fueled by the growing prevalence of lifestyle disorders among the expanding populations of China, India, and other economies, as well as the need to treat them with receptors.
Key players in the market
Some of the key players in G-Protein Coupled Receptors (GPCRs) market include Abcam PLC, Accure Pharma, Actelion, Addex Pharmaceuticals Ltd, Arena Pharmaceuticals, Inc., BD (Becton, Dickinson and Company), BioInvenu, Inc., Cisbio Bioassays, Corning Incorporated, Enzo Life Sciences, Inc., Eurofins DiscoverX, HD Biosciences Co., Ltd, Merck Group, Molecular Devices, LLC., PerkinElmer Inc., Promega Corporation, Qiagen, Thermo Fisher Scientific WuXi AppTec and Confo Therapeutics.
Key Developments:
In March 2023, Confo Therapeutics, a leader in targeting G-Protein Coupled Receptors (GPCRs) (GPCRs), this week announced an agreement with Daiichi Sankyo for the discovery and development of small molecule agonists against an undisclosed CNS target. Confo will receive upfront and milestone payments totaling $183 million and tiered royalties on sales from any resulting products.
In December 2022, Sosei Group Corporation announced its partnership with Eli Lilly and Company, a global biopharmaceutical firm. The collaboration aims to facilitate drug discovery for novel G protein-coupled receptor (GPCR) targets linked to diabetes and metabolic diseases, including the development and commercialization of small molecules with therapeutic potential.
In April 2022, Ono Pharmaceutical Co., Ltd. signed a new collaboration agreement with Domain Therapeutics and Universite de Montreal to discover novel small molecules targeting G-Protein Coupled Receptors (GPCRs) (GPCRs) in a metabolic disease area.
Products Covered:
• Cell Culture Reagents
• Cell Lines
• Detection Kits
• Ligands
Assay Types Covered:
• cAMP Functional Assays
• Calcium Functional Assays
• Internalization Assays
• Radioligand Binding and GTP?S Functional Assays
• Trafficking Assays
• ?-Arrestin Functional Assays
• Other Assay Types
Applications Covered:
• Cancer Research
• Cardiovascular Research
• Central Nervous System (CNS) Research
• Inflammation Research
• Metabolic Research
• Respiratory Research
• Other Applications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global G-Protein Coupled Receptors (GPCRs) Market, By Product
5.1 Introduction
5.2 Cell Culture Reagents
5.3 Cell Lines
5.4 Detection Kits
5.5 Ligands
6 Global G-Protein Coupled Receptors (GPCRs) Market, By Assay Type
6.1 Introduction
6.2 cAMP Functional Assays
6.3 Calcium Functional Assays
6.4 Internalization Assays
6.5 Radioligand Binding and GTP?S Functional Assays
6.6 Trafficking Assays
6.7 ?-Arrestin Functional Assays
6.8 Other Assay Types
7 Global G-Protein Coupled Receptors (GPCRs) Market, By Application
7.1 Introduction
7.2 Cancer Research
7.3 Cardiovascular Research
7.4 Central Nervous System (CNS) Research
7.5 Inflammation Research
7.6 Metabolic Research
7.7 Respiratory Research
7.8 Other Applications
8 Global G-Protein Coupled Receptors (GPCRs) Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Abcam PLC
10.2 Accure Pharma
10.3 Actelion
10.4 Addex Pharmaceuticals Ltd
10.5 Arena Pharmaceuticals, Inc.
10.6 BD (Becton, Dickinson and Company)
10.7 BioInvenu, Inc.
10.8 Cisbio Bioassays
10.9 Corning Incorporated
10.10 Enzo Life Sciences, Inc.
10.11 Eurofins DiscoverX
10.12 HD Biosciences Co., Ltd
10.13 Merck Group
10.14 Molecular Devices, LLC.
10.15 PerkinElmer Inc.
10.16 Promega Corporation
10.17 Qiagen
10.18 Thermo Fisher Scientific
10.19 WuXi AppTec
10.20 Confo Therapeutics
List of Tables
1 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Region (2021-2030) ($MN)
2 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
3 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
4 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
5 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
6 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
7 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
8 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
9 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
10 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
11 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTP?S Functional Assays (2021-2030) ($MN)
12 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
13 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By ?-Arrestin Functional Assays (2021-2030) ($MN)
14 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
15 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
16 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
17 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
18 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
19 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
21 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
22 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
23 Global G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
24 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Country (2021-2030) ($MN)
25 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
26 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
27 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
28 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
29 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
30 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
31 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
32 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
33 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
34 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTP?S Functional Assays (2021-2030) ($MN)
35 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
36 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By ?-Arrestin Functional Assays (2021-2030) ($MN)
37 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
38 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
39 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
40 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
41 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
42 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
44 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
45 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
46 North America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
47 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Country (2021-2030) ($MN)
48 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
49 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
50 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
51 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
52 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
53 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
54 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
55 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
56 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
57 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTP?S Functional Assays (2021-2030) ($MN)
58 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
59 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By ?-Arrestin Functional Assays (2021-2030) ($MN)
60 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
61 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
62 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
63 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
64 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
65 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
67 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
68 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
69 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
70 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Country (2021-2030) ($MN)
71 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
72 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
73 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
74 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
75 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
76 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
77 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
78 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
79 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
80 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTP?S Functional Assays (2021-2030) ($MN)
81 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
82 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By ?-Arrestin Functional Assays (2021-2030) ($MN)
83 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
84 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
85 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
86 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
87 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
88 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
90 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
91 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
92 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
93 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Country (2021-2030) ($MN)
94 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
95 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
96 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
97 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
98 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
99 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
100 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
101 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
102 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
103 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTP?S Functional Assays (2021-2030) ($MN)
104 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
105 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By ?-Arrestin Functional Assays (2021-2030) ($MN)
106 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
107 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
108 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
109 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
110 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
111 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
113 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
114 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
115 South America G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
116 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Country (2021-2030) ($MN)
117 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Product (2021-2030) ($MN)
118 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Culture Reagents (2021-2030) ($MN)
119 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cell Lines (2021-2030) ($MN)
120 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Detection Kits (2021-2030) ($MN)
121 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Ligands (2021-2030) ($MN)
122 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Assay Type (2021-2030) ($MN)
123 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By cAMP Functional Assays (2021-2030) ($MN)
124 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Calcium Functional Assays (2021-2030) ($MN)
125 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Internalization Assays (2021-2030) ($MN)
126 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Radioligand Binding and GTP?S Functional Assays (2021-2030) ($MN)
127 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Trafficking Assays (2021-2030) ($MN)
128 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By ?-Arrestin Functional Assays (2021-2030) ($MN)
129 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Assay Types (2021-2030) ($MN)
130 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Application (2021-2030) ($MN)
131 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cancer Research (2021-2030) ($MN)
132 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Cardiovascular Research (2021-2030) ($MN)
133 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Central Nervous System (CNS) Research (2021-2030) ($MN)
134 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Inflammation Research (2021-2030) ($MN)
136 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Metabolic Research (2021-2030) ($MN)
137 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Respiratory Research (2021-2030) ($MN)
138 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook, By Other Applications (2021-2030) ($MN)
List of Figures
List of Figures
Figure 1 Global G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 2 North America G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 3 US G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 4 Canada G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 5 Mexico G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 6 Europe G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 7 Germany G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 8 UK G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 9 Italy G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 10 France G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 11 Spain G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 14 Japan G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 15 China G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 16 India G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 17 Australia G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 19 South Korea G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 21 South America G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 22 Argentina G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 23 Brazil G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 24 Chile G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 28 UAE G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 29 Qatar G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 30 South Africa G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa G-Protein Coupled Receptors (GPCRs) Market Outlook (2021-2030) ($MN)
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
